History of Trent Ltd.

YEAR EVENTS 1952 - The Comp. was incorporated on 5th December, at Mumbai. It manufactures cosmetics, perfumery, toilet preparations, basic drugs, drug intermediates & formulations thereof.

1978 - 20,000 bonus shares issued in prop. 4:5.

1981 - 36,000 bonus shares issued in prop. 4:5.

1982 - The Tata Oil Mills Co. Ltd., offered for sale 4,17,000 No. of equity shares of Rs 10 each of Comp. at a premium of Rs 10 per share.

- 5,00,000 shares of Rs 10 each then issued [prem. Rs 10 per shares] of which 40,000 shares reserved for preferential allotment to the employees/business associates of Company. The balance 4,60,000 shares [along with reserved quota not taken up if anys] offered for public subscription during December.

1985 - In May/June, in order to augment the long-term resources for working capital requirements, the Comp. issued 15% non-convertible secured debentures of Rs 100 each of the aggregate value of Rs 1.25 crores on `Rights basis' in the proportion of one debenture for every 10 equity shares held. These debentures are redeemable at a premium of Rs 5 per share on the expiry of seven years from the date of allotment.

- The Comp. received separate industrial licence for the manufacture & exports of various types of medical equipment from Kandla Free Trade Zone.

- Application was also made for conversion of letter of intent into Industrial Licence in respect of project for the manufacture of pharmaceutical formulations.

- 5,24,000 bonus shares issued in prop. 2:5 in March 1986.

1986 - Two separate undertakings were established for manufacture of medical equipments & pharmaceutical formulations respectively at the Kandla Free Trade Zone.

- The Comp. issued 2,75,000-13.5% secured redeemable convertible debentures of Rs 100 each as follows: [is] 2,62,000 debentures to the existing equity shares holders on rights basis in the ratio of 1 debenture for 7 equity shares held & [iis] 13,000 debentures to the employees/workers on equitable basis.

- Out of employees' quota only 7,690 debentures were taken up & the balance 5,310 debentures were allowed to lapse. Thus a total of 2,69,690 debentures were allotted.

- A portion of Rs 25 of each debenture was compulsorily converted into 1 equity share of Rs 10 each at a premium of Rs 15 on the expiry of 1 year from the date of allotment. The remaining portion of Rs 75 of each debenture, after conversion, would be redeemed at par at the end of 7 years from the date of allotment.

1988 - The cosmetics division launched two new products which were well received in the market.

- The Company industrial undertakings at Kandla Free Trade Zone [KAFTZs] Gandhidham, Kutch, Gujarat, engaged exclusively in exports, was sold as a going concern to the Company wholly owned subsidiary `Lakme Exports Ltd.' Lakme Exports Ltd., were also to take over the services of all employees at KAFTZ.

1989 - 10,04,437 No. of equity shares issued [prem. Rs 75 per shares] as rights & to employees. Another 1,04,500 No. of equity shares of Rs 10 each allotted as fully paid up to the shareholders of Bruel Investments Ltd.

1991 - The Comp. has initiated steps to enhance its exports to general currency area. The Pharmaceuticals division continued to be affected by high cost of raw materials without any commensurate increase in the selling prices.

- The Breul Investments limited has become a subsidiary of the Company.

1992 - Breul Investments limited was amalgamated with the Comp. with effect from 1st April. As per the terms of scheme 1,04,500 No. of equity shares of Rs 10 each of Comp. were allotted to the shareholders of BIL in the portion of 55 No. of equity shares of Comp. for each share held in BIL.

1994 - The new products introduced by Cosmetics divisions viz., 'Ultra' & the 'Orchids' ranges in colour cosmetics fields were well received in the market.

- With a view to focus & concentrate on the core business of cosmetics & personal care products & ensure growth of pharm business, the Comp. decided to restructure the business by selling the pharmaceutical division called the Tata Pharma to a proposed new Comp. called 'Tata Pharma Pvt. Ltd.'

- Miaami Pharma and Chemicals limited [MPCLs], was merged with Lakme Ltd. effective 1st January, as per the scheme approved by BIFR. On 9.12.1994, the shareholders of erstwhile MPCL were allotted one equity share of each of Lakme Ltd., for every 45 shares held by them in MPCL. Accordingly, 1,09,333 shares were allotted.

1995 - A new product range `Elle 18' as well as several new products and variants were introduced during the year & were very well received in the market.

- The Comp. formed a joint venture, Lakme Lever Ltd., with Hindustan Lever Ltd., to which the Comp. has transferred its sales & marketing of cosmetic operations.

- 67,10,707 Bonus shares issued in proportion 1:1.

1996 - On 1st January, the Comp. has formed a subsidiary, Lakme Brands limited to acquire all the trade marks, technology, R&D infrastructure & brands of parent Company.

1999 - Name changed to Trent limited with effect from 28-06-1999.

2000 - Lakme has introduced a new range of Lakme Pure Radiance Blusher.

2007

-Trent Ltd has entered into an Agreement with The Xander Group Inc., a global private equity firm.

-The Comp. has issued rights in the ratio of 1:5 at a premium of Rs.490/-Per Share.

2009

- Trent Ltd has appointed Mr. Mehernosh M. Surti as Comp. Secretary & Compliance Officer of Trent Limited w.e.f. April 01, 2009 in place of Mrs. H. R. Wadia.